Instil Bio, Inc.

NASDAQ:TIL

Biotechnology

Healthcare
$7.45 +0.13%

+$0.01 today

Market cap
$50.53M
Beta
1.91
P/E (TTM)
-1.1
EPS (TTM)
-$6.99
52W Low $5.67High $33.83

Volume 0.02M

Average 0.03M

TIL Weighted Avg Shares (Diluted)

Average shares outstanding including dilutive securities, used to calculate diluted EPS.

Instil Bio, Inc.NASDAQ: TIL

Weighted Avg Shares (Diluted) · Q1 FY2026 · quarter ended Mar 2026

Weighted avg shares (diluted) grows in line with its trailing trend

Q1 FY2026 weighted avg shares (diluted) of 6.78M shares rose 3.8% year over year, ahead of the +3.3% change in trailing-twelve-month weighted avg shares (diluted). Sequentially, it rose 0.0% from the prior quarter. Over 3 fiscal years it compounded at +1.0% a year.

Context

  • Weighted avg shares (diluted) increased in 3 of the last 3 fiscal years.
  • FY2025 was the highest annual figure in the 4 fiscal years shown.

What to watch

Whether quarterly growth of +3.8% holds above the trailing-twelve-month pace of +3.3%.

Sources:Income StatementText generated from reported figures; not investment advice.

Latest quarterMar 2026
6.78M+0.0% QoQ
Last fiscal yearDec 2025
6.67M+2.4% YoY
LTMMar 2026
6.73M+3.3% YoY
Weighted Avg Shares (Diluted) past and forecast growth by horizon
Horizon Past Forecast Difference
Quarter+3.8%——
1 year+2.4%——
3-year CAGR+1.0%——
5-year CAGR——
10-year CAGR——

Weighted Avg Shares (Diluted) history

Shares · from the income statement

Latest · FY2025
6.67M USD
Year-over-year change
+2.4%
4-year CAGR
+5.9%

Weighted Avg Shares (Diluted) vs competitors

How TIL compares with its peers on the latest reported figures

  • TIL's LTM Mar 2026 weighted avg shares (diluted) of 6.73M shares is the lowest of the 9 companies compared; the peer median is 69.02M shares.
  • Its year-over-year change of +3.3% is the 6th highest of 9, against a peer median of +21.2%.
  • Over three fiscal years its annual growth of +1.0% compares with a peer median of +16.5%.
TIL Competitors Peer median
Weighted Avg Shares (Diluted) for TIL and competitors
Company Period LTM YoY 3-year CAGR
ONCYOncolytics Biotech Inc.LTM Mar 2026100.12M +27.6%+18.2%
STTKShattuck Labs, Inc.LTM Mar 202684.8M +66.7%+18.0%
ZNTLZentalis Pharmaceuticals, Inc.LTM Mar 202671.52M +0.4%+10.8%
WHWKWhitehawk Therapeutics IncLTM Mar 202669.18M +155.7%+40.1%
IFRXInflaRx N.V.LTM Mar 202668.86M +14.8%+15.0%
MGNXMacroGenics, Inc.LTM Mar 202663.26M +0.8%+0.9%
PLRXPliant Therapeutics, Inc.LTM Mar 202661.49M +1.3%+13.5%
SRZNSurrozen, Inc.LTM Mar 20269.29M +179.8%+47.8%
TILInstil Bio, Inc.LTM Mar 20266.73M +3.3%+1.0%
Peer median (excluding TIL) 69.02M+21.2%+16.5%

Competitors are the stored peer set for TIL. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Income Statement

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Revenue00000
Cost of Revenue05.99M00534K
Gross Profit0(5.99M)00(534K)
Gross Margin—————
Research & Development107.25M141.06M39.6M11.84M10M
Selling, General & Admin51.31M62.24M47.55M44.21M27.22M
Operating Expenses155.56M200.18M159.17M73.54M52.37M
Depreciation & Amortization2.75M5.99M4.76M3.61M534K
EBITDA(152.51M)(217.38M)(147.12M)(62.53M)(65.01M)
EBITDA Margin—————
Operating Income(155.56M)(206.17M)(159.17M)(73.54M)(52.91M)
Operating Margin—————
Interest Income80K3.66M8.87M6.99M3.86M
Interest Expense01.88M5.21M8.99M5.83M
Other Income / Expenses(1.2M)(19.08M)3.08M(594K)(18.47M)
Income Before Tax(156.76M)(225.25M)(156.09M)(74.14M)(71.37M)
Pre-Tax Margin—————
Income Tax Expense39K(2.07M)000
Net Income(156.79M)(223.18M)(156.09M)(74.14M)(71.37M)
Net Margin—————
EPS (Basic)(29.60)(34.46)(24.00)(11.39)(10.70)
EPS (Diluted)(29.60)(34.46)(24.00)(11.39)(10.70)
Weighted Avg Shares5.3M6.48M6.5M6.51M6.67M
Weighted Avg Shares (Diluted)5.3M6.48M6.5M6.51M6.67M

Instil Bio, Inc.

NASDAQ:TIL

Intrinsic Alpha fair value

Locked

Current Price

$7.45

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.